DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer

Condition:   Small Cell Lung Cancer Interventions:   Drug: DS-3201b;   Drug: irinotecan Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials